Compare with - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

KRSNAA DIAGNOSTICS vs KAYA - Comparison Results

Rs 100 invested in...

Loading...
DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    KRSNAA DIAGNOSTICS KAYA KRSNAA DIAGNOSTICS/
KAYA
 
P/E (TTM) x - -29.2 - View Chart
P/BV x 9.5 10.8 88.1% View Chart
Dividend Yield % 0.0 0.0 -  

Financials

 KRSNAA DIAGNOSTICS   KAYA
EQUITY SHARE DATA
    KRSNAA DIAGNOSTICS
Mar-21
KAYA
Mar-21
KRSNAA DIAGNOSTICS/
KAYA
5-Yr Chart
Click to enlarge
High RsNA379 0.0%   
Low RsNA117 0.0%   
Sales per share (Unadj.) Rs998.8210.5 474.4%  
Earnings per share (Unadj.) Rs284.5-28.6 -993.2%  
Cash flow per share (Unadj.) Rs342.117.4 1,965.3%  
Dividends per share (Unadj.) Rs00-  
Avg Dividend yield %NM0- 
Book value per share (Unadj.) Rs355.541.7 852.1%  
Shares outstanding (eoy) m6.5013.06 49.8%   
Bonus / Rights / Conversions ---  
Price / Sales ratio x01.2 0.0%   
Avg P/E ratio x0-8.7 0.0%  
P/CF ratio (eoy) x014.3 0.0%  
Price / Book Value ratio x05.9 0.0%  
Dividend payout %00-   
Avg Mkt Cap Rs m03,240 0.0%   
No. of employees `000NANA-   
Total wages/salary Rs m2961,153 25.7%   
Avg. sales/employee Rs ThNMNM-  
Avg. wages/employee Rs ThNMNM-  
Avg. net profit/employee Rs ThNMNM-  
INCOME DATA
Net Sales Rs m6,4922,750 236.1%  
Other income Rs m122148 82.8%   
Total revenues Rs m6,6152,898 228.3%   
Gross profit Rs m3,466269 1,286.8%  
Depreciation Rs m374601 62.2%   
Interest Rs m259190 136.6%   
Profit before tax Rs m2,955-374 -789.8%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m1,1050-   
Profit after tax Rs m1,849-374 -494.3%  
Gross profit margin %53.49.8 545.0%  
Effective tax rate %37.40-   
Net profit margin %28.5-13.6 -209.4%  
BALANCE SHEET DATA
Current assets Rs m2,481779 318.7%   
Current liabilities Rs m1,8381,818 101.1%   
Net working cap to sales %9.9-37.8 -26.2%  
Current ratio x1.40.4 315.1%  
Inventory Days Days2529 86.5%  
Debtors Days Days4144 92.6%  
Net fixed assets Rs m3,5642,902 122.8%   
Share capital Rs m2,489131 1,905.1%   
"Free" reserves Rs m-178414 -43.1%   
Net worth Rs m2,310545 424.1%   
Long term debt Rs m1,680286 587.0%   
Total assets Rs m6,0453,681 164.2%  
Interest coverage x12.4-1.0 -1,276.7%   
Debt to equity ratio x0.70.5 138.4%  
Sales to assets ratio x1.10.7 143.8%   
Return on assets %34.9-5.0 -696.9%  
Return on equity %80.0-68.7 -116.6%  
Return on capital %80.5-22.2 -363.3%  
Exports to sales %00-   
Imports to sales %07.2 0.0%   
Exports (fob) Rs mNANA-   
Imports (cif) Rs mNA199 0.0%   
Fx inflow Rs m094 0.0%   
Fx outflow Rs m0199 0.0%   
Net fx Rs m0-105 0.0%   
CASH FLOW
From Operations Rs m1,026316 324.4%  
From Investments Rs m-61143 -1,413.3%  
From Financial Activity Rs m308-307 -100.3%  
Net Cashflow Rs m72349 1,461.5%  

Share Holding

Indian Promoters % 27.4 59.8 45.8%  
Foreign collaborators % 0.0 0.1 -  
Indian inst/Mut Fund % 36.2 2.2 1,658.7%  
FIIs % 6.0 0.7 821.9%  
ADR/GDR % 0.0 0.0 -  
Free float % 72.6 40.1 181.2%  
Shareholders   75,554 26,661 283.4%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare KRSNAA DIAGNOSTICS With:   THYROCARE TECHNOLOGIES  KMC SPECIALITY HOSPITALS  MAX HEALTHCARE INSTITUTE  ASPIRA PATHLAB & DIAGNOSTICS   NIDAN LABORATORIES AND HEALTHCARE  



Today's Market

Sensex Ends 153 Points Higher; Kotak Mahindra Bank & HCL Tech Among Top Nifty Gainers(Closing)

Indian share markets witnessed volatile trading activity throughout the day today and ended marginally higher.

Related Views on News

KAYA 2020-21 Annual Report Analysis (Annual Result Update)

Nov 9, 2021 | Updated on Nov 9, 2021

Here's an analysis of the annual report of KAYA for 2020-21. It includes a full income statement, balance sheet and cash flow analysis of KAYA. Also includes updates on the valuation of KAYA.

More Views on News

Most Popular

Infosys vs TCS: Which is Better?(Views On News)

Nov 26, 2021

In the post pandemic era, the top two IT companies in India are fighting to capture the growing demand for IT.

This Multibagger Stock Zooms 20% After Dolly Khanna Buys Stake(Views On News)

Nov 24, 2021

Shares of this edible oil company zoomed over 50% in three days after ace investor bought around 1% stake.

Don't Sell these Stocks if the Market Falls(Profit Hunter)

Nov 17, 2021

These are the 3 types of stocks that you should not sell in a market crash.

MobiKwik IPO Opens for Subscription Soon. Key Things to Know Before Subscribing.(Views On News)

Nov 20, 2021

The Rs 19 bn issue is set to hit the market soon.

How to Find Your Next 10-Bagger in this Market(Profit Hunter)

Nov 19, 2021

The #1 make or break factor in your portfolio you shouldn't ignore.

More

Become A Smarter Investor
In Just 5 Minutes

Multibagger Stock Guide 2022
Get our special report Multibagger Stocks Guide (2022 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

KRSNAA DIAGNOSTICS SHARE PRICE


Nov 29, 2021 (Close)

TRACK KRSNAA DIAGNOSTICS

  • Track your investment in KRSNAA DIAGNOSTICS with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON KRSNAA DIAGNOSTICS

KRSNAA DIAGNOSTICS - KMC SPECIALITY HOSPITALS COMPARISON

COMPARE KRSNAA DIAGNOSTICS WITH

MARKET STATS